Literature DB >> 22823432

Extrathymic CD4+CD8+ lymphocytes in Chagas disease: possible relationship with an immunoendocrine imbalance.

Ana R Pérez1, Alexandre Morrot, Luiz R Berbert, Eugenia Terra-Granado, Wilson Savino.   

Abstract

Double-positive (DP) CD4(+) CD8(+) T cells normally represent a thymic subpopulation that is developed in the thymus as a precursor of CD4(+) or CD8(+) single-positive T cells. Recent evidence has shown that DP cells with an activated phenotype can be tracked in secondary lymph organs. The detection of an activated DP population in the periphery, a population that expresses T cell receptors unselected during thymic negative selection in murine models of Trypanosoma cruzi infection and in humans with Chagas disease, raise new questions about the relevance of this population in the pathogenesis of this major parasitic disease and its possible link with immunoendocrine alterations.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22823432     DOI: 10.1111/j.1749-6632.2012.06627.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.

Authors:  Carylinda Serna; Joshua A Lara; Silas P Rodrigues; Alexandre F Marques; Igor C Almeida; Rosa A Maldonado
Journal:  Vaccine       Date:  2014-04-30       Impact factor: 3.641

2.  Analysis of CD4+ CD8+ double-positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions.

Authors:  A Waschbisch; L Sammet; S Schröder; D-H Lee; A Barrantes-Freer; C Stadelmann; R A Linker
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

3.  Anti-RANKL Inhibits Thymic Function and Causes DRONJ in Mice.

Authors:  Yusuke Nakamura; Takashi Kikuiri; Takahiro Sugiyama; Ayako Maeda; Daisuke Izumiyama; Daigo Yahata; Yoshitaka Yoshimura; Tetsuo Shirakawa; Yoshimasa Kitagawa
Journal:  Int J Dent       Date:  2022-04-15

4.  Host Genetics Background Influence in the Intragastric Trypanosoma cruzi Infection.

Authors:  Carolina Salles Domingues; Flávia de Oliveira Cardoso; Daiana de Jesus Hardoim; Marcelo Pelajo-Machado; Alvaro Luiz Bertho; Kátia da Silva Calabrese
Journal:  Front Immunol       Date:  2020-11-24       Impact factor: 7.561

5.  Indeterminate Form of Chagas Disease: Some Immunological Insights.

Authors:  Daniel Mazza Matos; Carlos Eduardo Menezes Viana; Maria de Fátima Oliveira; José Ajax Nogueira Queiroz
Journal:  Rev Soc Bras Med Trop       Date:  2022-04-29       Impact factor: 2.141

6.  Trypanosoma cruzi disrupts thymic homeostasis by altering intrathymic and systemic stress-related endocrine circuitries.

Authors:  Ailin Lepletier; Vinicius Frias de Carvalho; Patricia Machado Rodrigues e Silva; Silvina Villar; Ana Rosa Pérez; Wilson Savino; Alexandre Morrot
Journal:  PLoS Negl Trop Dis       Date:  2013-11-14

Review 7.  Acute chagas disease: new global challenges for an old neglected disease.

Authors:  Daniela V Andrade; Kenneth J Gollob; Walderez O Dutra
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31

8.  Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.

Authors:  Elena Pérez-Antón; Adriana Egui; M Carmen Thomas; Concepción J Puerta; John Mario González; Adriana Cuéllar; Manuel Segovia; Manuel Carlos López
Journal:  PLoS Negl Trop Dis       Date:  2018-05-11

Review 9.  Role of Hormonal Circuitry Upon T Cell Development in Chagas Disease: Possible Implications on T Cell Dysfunctions.

Authors:  Ana Rosa Pérez; Alexandre Morrot; Vinicius Frias Carvalho; Juliana de Meis; Wilson Savino
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-14       Impact factor: 5.555

Review 10.  The Thymus in Chagas Disease: Molecular Interactions Involved in Abnormal T-Cell Migration and Differentiation.

Authors:  Ana Rosa Pérez; Juliana de Meis; Maria Cecilia Rodriguez-Galan; Wilson Savino
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.